Early research (Phase 1)Ended earlyNCT06336148What this trial is testingA Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Actym Therapeutics, Inc. 10
Testing effectiveness (Phase 2)WithdrawnNCT01679743What this trial is testingGRN1005 for Brain Metastases From Breast or Lung CancerWho this might be right forBreast CancerLung NeoplasmsBreast Neoplasms+1 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT03997968What this trial is testingCYT-0851 in B-Cell Malignancies and Advanced Solid TumorsWho this might be right forMalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more Cyteir Therapeutics, Inc. 169
Testing effectiveness (Phase 2)Ended earlyNCT05180474What this trial is testingGEN1047 for Solid Tumors - First in Human (FIH) TrialWho this might be right forBreast Cancer, Breast NeoplasmsEndometrial Cancer, Endometrial NeoplasmOvarian Cancer, Ovarian Neoplasms+1 more Genmab 179
Testing effectiveness (Phase 2)Ended earlyNCT01029925What this trial is testingDichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)Who this might be right forMetastatic Breast CancerLung Cancer Jonsson Comprehensive Cancer Center 7
Testing effectiveness (Phase 2)Ended earlyNCT04442126What this trial is testingNM21-1480 in Adult Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorNon-small Cell Lung CancerColorectal Cancer+6 more Numab Therapeutics AG 52
Not applicableStudy completedNCT00416689What this trial is testingNausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung CancerWho this might be right forBreast CancerLung CancerNausea and Vomiting Alliance for Clinical Trials in Oncology 99
Early research (Phase 1)Study completedNCT00045006What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01325558What this trial is testingALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced Malignant NeoplasmMalignant Solid Tumour Altor BioScience 30
Early research (Phase 1)Study completedNCT00228358What this trial is testingCyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu VaccineWho this might be right forHER2-positive Breast CancerRecurrent Breast CancerRecurrent Non-small Cell Lung Cancer+6 more University of Washington 8
Early research (Phase 1)Looking for participantsNCT04389632What this trial is testingSigvotatug Vedotin in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more Seagen, a wholly owned subsidiary of Pfizer 1,006
Testing effectiveness (Phase 2)Ended earlyNCT03724253What this trial is testing[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)Who this might be right forBreast CancerProstate CancerColorectal Cancer+2 more Advanced Accelerator Applications 19
Early research (Phase 1)Looking for participantsNCT07334119What this trial is testingSafety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsWho this might be right forHER2-Expressing Solid Tumors Myeloid Therapeutics 60
Testing effectiveness (Phase 2)Looking for participantsNCT05272709What this trial is testingTT-702 in Patients With Advanced Solid Tumours.Who this might be right forAdvanced Solid Tumors Cancer Research UK 60
Testing effectiveness (Phase 2)Looking for participantsNCT07189871What this trial is testing177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsWho this might be right forCastration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more Radiopharm Theranostics, Ltd 61
Not applicableEnded earlyNCT05891197What this trial is testingA Biomarker Screening Protocol for Participants With Solid TumorsWho this might be right forTriple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more Lyell Immunopharma, Inc. 10
Not applicableStudy completedNCT00905086What this trial is testingPsychosocial Adjustment After Radiation Therapy in Patients With CancerWho this might be right forBreast CancerCognitive/Functional EffectsColorectal Cancer+3 more Case Comprehensive Cancer Center 80
Early research (Phase 1)Study completedNCT03595059What this trial is testingA Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 168
Early research (Phase 1)Ended earlyNCT00937482What this trial is testingCediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerWho this might be right forMale Breast CancerStage IV Breast CancerStage IV Melanoma+7 more National Cancer Institute (NCI) 18
Not applicableWithdrawnNCT03408561What this trial is testingSocial Media Listening in Improving Clinical Trial Recruitment in Patients With CancerWho this might be right forBreast CarcinomaColon CarcinomaKidney Carcinoma+3 more University of Southern California